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Abstract
Background: Gaucher's disease (GD) is the most frequently encountered lysosomal storage
disease. Here, we describe and discuss the observed concurrence of schizophrenia and Gaucher's
disease in two siblings.
Methods: Presentation of a family with two siblings with Gaucher's disease.
Results: In a six-member family, the first son suffers from schizophrenia, while the third and fourth
sons suffer from the Gaucher's disease (type 1 non-neuronopathic). The parents and the second
son do not suffer from either illness.
Conclusion: The concurrence of schizophrenia and Gaucher's disease in the same family is an
unusual phenomenon. The literature regarding this coincidence is limited, despite the fact that
patients with Gaucher's disease have one or two mutated alleles, considered to be a risk factor
leading to conditions such as Dementia, Parkinson's disease and schizophrenia.
Introduction
Gaucher's disease (GD) is the most frequently encoun-
tered lysosomal storage disease [1] caused by autosomal
recessive inborn defects in the glucocerebrosidase gene
(GBA) at the 1q21 chromosome [2,3]. These defects even-
tually lead to accumulation of the glycolipid in lysosomes
within macrophages of the reticuloendothelial system.
Clinically, GD can present with a vast phenotypic hetero-
geneity [4], which can be predicted to some extent from
the underlying mutation [5]. Three clinical forms of GD
have been identified: type 1 non-neuronopathic, type 2
acute neuronopathic, and type 3 subacute neuronopathic
[6]. The concurrence of Gaucher's disease and schizophre-
nia among siblings is a very rare phenomenon. In the
present work, we describe a family with four sons, two of
whom suffer from Gaucher's disease and another from
schizophrenia, with one being free from any illness.
Presentation of the family
In this six-member family, the first son displayed para-
noid type of schizophrenia and the third and fourth sons
displayed Gaucher's disease type 1, non-neuronopathic.
The 23-year-old first son's symptoms, manifested from
January 2003 for a period of 5 months. He reported a loss
of interest for work, depression of moderate intensity and
social withdrawal. In June 2003, he presented with an
acute psychotic episode with delusional ideas of control
of affect and auditory hallucinations in the form of voices
in the third person, depreciatory for the patient. He also
had interruptions in the flow of thought, with speech
inconsistency, psychomotor excitation and aggressive
behaviour directed towards members of his family. No
physical illness or illicit substance use were detected. The
brain neuroimaging examinations (CT and MRI) were
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normal. During his psychiatric hospitalisation, he was put
on 8 mg risperidone and 4 mg biperiden per day. Psycho-
motor excitation and aggressive behaviour were amelio-
rated. However, the delusional ideas and the auditory
hallucinations, as well as the disordered thinking,
remained. On September 2003, he displayed extrapyram-
idal symptoms and unexpectedly severe symptoms resem-
bling to tardive dyskinesia. His medication was changed
to olanzapine, 10 mg daily, which contributed to the con-
siderable amelioration of these side effects. He was nega-
tive for Gaucher's disease on examination.
The 12-year-old brother had been hospitalised for unspec-
ified feverish disease lasting for weeks when he was 9 (2
years before displaying Gaucher's disease), and there were
frequent infections in his clinical background. During the
clinical and laboratorial examination, cytopenia and
splenomegaly were diagnosed. A bone marrow examina-
tion showed Gaucher's disease. More detailed tests and
general neurological, laboratorial and clinical examina-
tions showed no neurological dysfunction. The final diag-
nose was Gaucher's disease, type 1, non-neuronopathic.
Since that time, he has been under medication with intra-
venous infusions of glucocerebrosidase. The spleen size
has become normal and the cytopenia improved. No
other physical or psychiatric disease has been found.
After the diagnosis of Gaucher's disease was made for the
patient, the whole family was submitted to special tests
for this disease. The control test was negative for the
whole family, except the patient's 17-year-old brother.
The bone marrow examination for the Gaucher's disease
was positive in this case, while inflation in both sides of
the knees was observed on clinical examination. There
was no neurological involvement, not any other physical
or psychiatric disease. Since that time, he has undergone
medical treatment with infusion of glucocerebrosidase
intravenously each week. No other member of the family
suffers from Gaucher's disease or schizophrenia. In fact,
the psychiatric examination did not reveal any other psy-
chiatric illness for any other member of the family.
The medical examination did not reveal any other mor-
bidity in any member of the family.
Discussion
Perez-Calvo et al [7] presented the results of a co-morbid-
ity study regarding Gaucher's disease from a nationwide
enquiry in Spain. The aim of that study was to determine
if Gaucher's disease patients and non-affected carriers
have a risk of suffering from other diseases when com-
pared to healthy non-carrier relatives. The results indi-
cated that the Gaucher's patients or carriers have a
relatively higher risk of suffering from any other disease:
patient vs healthy 9.69, patient vs carrier 3.74, carrier vs
healthy 2.59. The relative risk of suffering from any dis-
ease, regarding the patients' and carriers' sex, was 3.96 for
female patients and 1.34 for female carriers. This study
shows that Gaucher's patients, as a group, seem to have a
greater risk, estimated by p values, of suffering from other
common unrelated diseases, including schizophrenia,
than carriers or healthy relatives. This excess of risk is par-
ticularly high among female patients.
Epidemiological studies [8] have demonstrated at least
50% higher rates of schizophrenia among European
Ashkenazi Jews, compared to their non-European Jewish
counterparts. Type 1 Gaucher's disease is the most com-
mon genetic illness among the Ashkenazim. The inci-
dence is estimated to be between 1 in 600 and 1 in 2 500,
with a heterozygote frequency of about 1 in 13 in this
population [9]. Gaucher's disease is caused by allelic vari-
ations of the lysosomal enzyme glucocerebrosidase. The
gene locus is at the chromosome 1q21. In particular, the
N3705 mutation at the GBA locus on human chromo-
some 1q21 has a more than 70% frequency in the
Ashkenazim [10], and is the second most widespread
Gaucher's disease mutation in the European non-Jewish
population, with a high frequency among Portuguese and
Spanish patients [11,12].
Goodman [13], in order to limit the genetic heterogeneity
of schizophrenia, focused on testing the hypothesis that
an increased prevalence of the lysosomal enzyme disor-
ders of Gaucher's disease might contribute to the demon-
strated increased vulnerability to schizophrenia among
the Ashkenazim. The study showed that, among the
Ashkenazim, schizophrenic symptoms might be variable
phenotypic expressions of the underlying genetic diseases,
such as Gaucher's disease.
Herrlin et al [14] reported behaviour disorders and psy-
chotic symptoms in individuals suffering from the juve-
nile form of Gaucher's disease. Neil et al [15] described a
family in which classical non-neuronopathic Gaucher's
disease type 1 was years later followed by dementing neu-
rologic and atypical psychotic disorders. The occurrence
of Gaucher's disease in two successive generations is
extremely rare, and has only been described in three cases.
The proband, a 41-year-old woman who had received a
diagnosis of asymptomatic Gaucher's disease at the age of
21, had her first psychotic episode at age 40 and a second
one a year later. Her clinical presentation was marked by
prominent affective lability, depression with intermittent
episodes of euphoria, paranoia, multiple phobias,
somatic delusions and recurrent impulsive suicidal acts.
The proband's 40-year-old brother had been hospitalized
on three occasions between the ages of 28 and 32. In addi-
tion, he had a medical background with psychiatric
admissions to three other hospitals each time after anPublish with BioMed Central    and   every 
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acute psychotic episode. Gaucher's disease had first been
diagnosed by bone marrow examination, 8 years prior to
the onset of psychiatric symptoms. The proband's mother,
at age 50, displayed paranoid ideation, somatic delusions
and movement disorders. A second episode a year later
was similar, but more severe. She died at the age of 62 dur-
ing a complicated surgical procedure on an unexplained
fracture on her left hip. Unfortunately, autopsy studies
were performed in a perfunctory fashion and examina-
tions that might have demonstrated evidence of Gaucher's
disease were omitted.
Conclusion
The concurrence of schizophrenia and Gaucher's disease
in the same family is an unusual phenomenon. The liter-
ature regarding the coincidence of Gaucher's disease and
schizophrenia in the same family is limited, despite the
fact that patients with Gaucher's disease have one or two
mutated alleles, considered to be risk factors leading to
conditions, such as Dementia, Parkinson's disease and
schizophrenia.
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